NASDAQ:VIVEViveve Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Viveve Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.61 -0.03 (-4.94 %) (As of 08/11/2020 04:00 PM ET) Add Compare Share Today's Range$0.61Now: $0.61▼$0.6450-Day Range$0.56MA: $0.59▼$0.6552-Week Range$0.53Now: $0.61▼$18.00Volume567,794 shsAverage Volume1.55 million shsMarket Capitalization$9.49 millionP/E RatioN/ADividend YieldN/ABeta0.39 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Viveve Medical. Previous Next 3.0 Community Rank Outperform VotesViveve Medical has received 300 “outperform” votes. (Add your “outperform” vote.)Underperform VotesViveve Medical has received 203 “underperform” votes. (Add your “underperform” vote.)Community SentimentViveve Medical has received 59.64% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Viveve Medical and other stocks. Vote “Outperform” if you believe VIVE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VIVE will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldViveve Medical does not currently pay a dividend.Dividend GrowthViveve Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Viveve Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.96% of the stock of Viveve Medical is held by insiders.Percentage Held by InstitutionsOnly 0.72% of the stock of Viveve Medical is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Viveve Medical are expected to grow in the coming year, from ($2.43) to ($1.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Viveve Medical is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Viveve Medical is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioViveve Medical has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.85 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VIVE Previous SymbolOTCMKTS:PLCSD CUSIPN/A CIK879682 Webwww.viveve.com Phone720-696-8100Debt Debt-to-Equity Ratio0.33 Current Ratio3.70 Quick Ratio2.73Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$6.57 million Price / Sales1.44 Cash FlowN/A Price / Cash FlowN/A Book Value$2.34 per share Price / Book0.26Profitability EPS (Most Recent Fiscal Year)($33.80) Net Income$-42,530,000.00 Net Margins-822.47% Return on Equity-25,840.09% Return on Assets-161.54%Miscellaneous Employees67 Outstanding Shares15,655,000Market Cap$9.49 million Next Earnings Date8/13/2020 (Confirmed) OptionableOptionable $0.61 -0.03 (-4.94 %) (As of 08/11/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive VIVE News and Ratings via Email Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions How has Viveve Medical's stock been impacted by COVID-19 (Coronavirus)? Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VIVE shares have decreased by 27.8% and is now trading at $0.6064. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Viveve Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Viveve Medical. When is Viveve Medical's next earnings date? Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Viveve Medical. How can I listen to Viveve Medical's earnings call? Viveve Medical will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. How were Viveve Medical's earnings last quarter? Viveve Medical Inc (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, May, 14th. The company reported ($0.82) earnings per share (EPS) for the quarter, beating the consensus estimate of ($12.60) by $11.78. The firm earned $1.30 million during the quarter. Viveve Medical had a negative return on equity of 25,840.09% and a negative net margin of 822.47%. View Viveve Medical's earnings history. Has Viveve Medical been receiving favorable news coverage? News coverage about VIVE stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viveve Medical earned a news impact score of 1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Viveve Medical. Are investors shorting Viveve Medical? Viveve Medical saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 193,000 shares, an increase of 25.0% from the January 31st total of 154,400 shares. Based on an average trading volume of 2,430,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.8% of the company's shares are short sold. View Viveve Medical's Short Interest. Who are some of Viveve Medical's key competitors? Some companies that are related to Viveve Medical include IRIDEX (IRIX), CHF Solutions (CHFS), Helius Medical Technologies (HSDT), Second Sight Medical Products (EYES), Reshape Lifesciences (RSLS), ENDRA Life Sciences (NDRA), Precision Optics (PEYE), Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), ReShape Lifesciences (RSLSD), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA) and Echo Therapeutics (ECTE). View all competitors. What other stocks do shareholders of Viveve Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Western Digital (WDC), Novavax (NVAX) and Selecta Biosciences (SELB). Who are Viveve Medical's key executives? Viveve Medical's management team includes the following people: Mr. Scott C. Durbin, CEO & Director (Age 50)Mr. James Gregory Atkinson, Chief Bus. Officer & Pres (Age 61)Mr. Jim B. Robbins, VP of Fin. & Admin., Principal Accounting Officer and Principal Financial Officer (Age 55)Ms. Deborah A. Jorn, Sr. Advisor to the CEO & Director (Age 61)Mr. Martin Kerber, VP of Operations When did Viveve Medical IPO? (VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager. What is Viveve Medical's stock symbol? Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE." How do I buy shares of Viveve Medical? Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Viveve Medical's stock price today? One share of VIVE stock can currently be purchased for approximately $0.61. How big of a company is Viveve Medical? Viveve Medical has a market capitalization of $9.49 million and generates $6.57 million in revenue each year. The company earns $-42,530,000.00 in net income (profit) each year or ($33.80) on an earnings per share basis. Viveve Medical employs 67 workers across the globe. What is Viveve Medical's official website? The official website for Viveve Medical is www.viveve.com. How can I contact Viveve Medical? Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected] This page was last updated on 8/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
